VEGFA and neoplasm: Resistance to Bev therapy is thought to occur by various mechanisms including hypoxia‐induced activation of alternate angiogenic factors4, 5; vessel co‐option, the process whereby tumors utilize normal brain vessels to obtain oxygen and nutrients6; and inherent insensitivity of tumor vessels to VEGF signaling.7, 8